• Latest Posts

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

Biotech of the week: Nordic Nanovector & its ARC technology

When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease

New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas

Biotech of the week: Glycotope, the Biggest Biotech in Berlin

Ovarian Cancer Kills 50,000 Every Year. Now a French Biotech has Bagged €15M to Fight it.

ADVERTISEMENT

Delenex Therapeutics, the Swiss Biotech developing new types of Therapeutic Antibodies

How a Breakthrough Leukemia Drug is Shaping the Future of Bispecific T-Cell Therapies

Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck

Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!

Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

ADVERTISEMENT